- Home
- TDTH vs NRXP Comparison
TDTH vs NRXP Comparison
Compare TDTH & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDTH
- NRXP
- Stock Information
- Founded
- TDTH 2014
- NRXP 2015
- Country
- TDTH Singapore
- NRXP United States
- Employees
- TDTH N/A
- NRXP N/A
- Industry
- TDTH
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- TDTH
- NRXP Health Care
- Exchange
- TDTH NYSE
- NRXP Nasdaq
- Market Cap
- TDTH 42.7M
- NRXP 34.7M
- IPO Year
- TDTH 2024
- NRXP N/A
- Fundamental
- Price
- TDTH $0.35
- NRXP $2.05
- Analyst Decision
- TDTH
- NRXP Strong Buy
- Analyst Count
- TDTH 0
- NRXP 3
- Target Price
- TDTH N/A
- NRXP $31.67
- AVG Volume (30 Days)
- TDTH 2.7M
- NRXP 198.6K
- Earning Date
- TDTH 05-25-2025
- NRXP 03-17-2025
- Dividend Yield
- TDTH N/A
- NRXP N/A
- EPS Growth
- TDTH N/A
- NRXP N/A
- EPS
- TDTH N/A
- NRXP N/A
- Revenue
- TDTH $1,380,783.00
- NRXP N/A
- Revenue This Year
- TDTH N/A
- NRXP N/A
- Revenue Next Year
- TDTH N/A
- NRXP N/A
- P/E Ratio
- TDTH N/A
- NRXP N/A
- Revenue Growth
- TDTH 8.81
- NRXP N/A
- 52 Week Low
- TDTH $0.40
- NRXP $1.10
- 52 Week High
- TDTH $4.74
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- TDTH N/A
- NRXP 43.44
- Support Level
- TDTH N/A
- NRXP $1.95
- Resistance Level
- TDTH N/A
- NRXP $2.20
- Average True Range (ATR)
- TDTH 0.00
- NRXP 0.18
- MACD
- TDTH 0.00
- NRXP 0.02
- Stochastic Oscillator
- TDTH 0.00
- NRXP 26.09
About TDTH TRIDENT DIGITAL TECH HOLDINGS LTD SPON ADS EACH REP 8 ORD CL B
Trident Digital Tech Holdings is principally engaged in the provision of business consulting service and IT customization solutions in the Republic of Singapore.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.